小动物肝脏SPECT影像组学检测微小肿瘤病灶
该研究旨在验证一种基于SPECT肝活动分布直方图偏度与峰度的新分析方法,用于早期发现肿瘤病灶。研究使用四组小鼠(健康对照、肥胖、化学诱导原发性肝癌、人黑色素瘤肝转移),静脉注射99mTc标记的白蛋白纳米颗粒后行肝脏SPECT扫描。结果显示SUV、SUC和峰度无法区分健康与肿瘤组,但活动分布偏度可区分健康与肿瘤组。
要点
- 99mTc-白蛋白纳米颗粒肝脏SPECT活动分布偏度可区分健康与肿瘤组。
- SUV、SUC和峰度参数未能区分健康与肿瘤组。
- 视觉冷点检测在转移组中不是可靠的肿瘤组织标志。
核心结论
- 99mTc-白蛋白纳米颗粒注射后肝脏SPECT活动分布偏度计算是一种合适的图像分析工具,可定量研究肝巨噬细胞不均匀性并识别不可见但存在的肝脏冷点病灶。
- 偏度作为直接图像衍生参数能够在肝脏肿瘤灶视觉显现之前显示组织功能改变。
- 活动分布偏度可能与微观肿瘤负荷导致的巨噬细胞分布不均匀有关。
研究设计与样本
- 实验使用四组小鼠:健康对照组、高体重指数肥胖组、化学诱导肝细胞癌(HCC)原发肝癌组和人黑色素瘤(HM)肝转移组。
- SPECT测量前2小时静脉注射99mTc标记的聚集白蛋白纳米颗粒,使用NanoSPECT/CT(Silver Upgrade,Mediso Ltd.,匈牙利)成像肝脏巨噬细胞。
- 从分割的全肝体积计算活动分布的SUV、SUC、偏度和峰度。
主要发现
- HCC动物显示中等99mTc-白蛋白颗粒摄取,部分视觉可识别冷点提示肿瘤存在。
- 转移组中视觉冷点检测不是肿瘤组织的可靠标志。
- 计算得出的SUV、SUC和峰度参数无法区分健康组与肿瘤组。
- 通过比较活动分布的偏度,健康组与肿瘤组可被区分。
临床怎么用
- 基于99mTc-白蛋白纳米颗粒的肝脏SPECT活动分布偏度计算可作为定量分析工具,用于研究肝巨噬细胞不均匀性并识别不可见的肝脏冷点病灶。
- 偏度作为直接图像衍生参数,可在肝脏肿瘤灶视觉显现之前显示组织功能改变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Our aim was to present a new data analysis technique for the early detection of tumorous lesions using single-photon emission computed tomography (SPECT) imaging. Beyond standardized uptake value (SUV) and standardized uptake concentration (SUC), the skewness and kurtosis parameters of whole liver activity distribution histograms were examined in SPECT images to reveal the presence of tumorous cells. METHODS: Four groups of mice were used in our experiment: a healthy control group, a group of obese mice with high body mass index, and two tumorous groups (primary liver cancer group with chemically induced hepatocellular carcinoma (HCC); metastatic liver tumor group-xenograft of human melanoma (HM)). For the SPECT measurements, 99mTc-labeled aggregated albumin nanoparticles were administered intravenously 2 h before the liver SPECT scans (NanoSPECT/CT, Silver Upgrade, Mediso Ltd., Hungary) to image liver macrophages. Finally, SUV, SUC, skewness, and kurtosis of activity distributions were calculated from segmented whole liver volumes. RESULTS: HCC animals showed moderate 99mTc-albumin particle uptake with some visually identified cold spots indicating the presence of tumors. The visual detection of cold spots however was not a reliable marker of tumorous tissue in the metastatic group. The calculated SUV, SUC, and kurtosis parameters were not able to differentiate between the healthy and the tumorous groups. However, healthy and tumorous groups could be distinguished by comparing the skewness of the activity distribution. CONCLUSION: Based on our results, 99mTc-albumin nanoparticle injection followed by liver SPECT activity distribution skewness calculation is a suitable image analysis tool. This makes possible to effectively and quantitatively investigate liver macrophage inhomogeneity and identify invisible but present liver cold spot lesions. Skewness as a direct image-derived parameter is able to show altered tissue function even before the visual manifestation of liver tumor foci. The skewness of activity distribution might be related to an inhomogeneous distribution of macrophage cells as a consequence of microscopic tumor burden in the liver.
引用
- Veres DS, Máthé D, Hegedűs N, et al. Radiomic detection of microscopic tumorous lesions in small animal liver SPECT imaging. EJNMMI Res. 2019. PMID: 31346827. doi:10.1186/s13550-019-0532-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。